Optiver Holding
ADCT icon

Optiver Holding’s ADC Therapeutics ADCT Stock Holding History

Optiver Holding’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9K Buy
2,706
+1,840
+212% +$5.37K ﹤0.01% 2186
2026
Q1 		$3.25K Buy
866
+280
+48% +$1.1K ﹤0.01% 1620
2025
Q4 		$2.07K Sell
586
-720
-55% -$2.92K ﹤0.01% 2000
2025
Q3 		$5.22K Buy
+1,306
New +$4.12K ﹤0.01% 1707

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Optiver Holding's ADCT Position: Q2 2026 in Review

Optiver Holding increased its ADC Therapeutics (ADCT) stake by 212% in Q2 2026, buying an estimated $5.37K and bringing the position to 2,706 shares worth $2.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

Optiver Holding first reported a position in ADCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.22K in Q3 2025. 113 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Optiver Holding held 2,706 shares of ADC Therapeutics worth $2.9K as of Q2 2026.
  • Optiver Holding bought 1,840 ADC Therapeutics shares in Q2 2026, an estimated $5.37K.
  • ADC Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2186 holding.
  • Optiver Holding first reported a position in ADC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's ADC Therapeutics position peaked at $5.22K in Q3 2025.
  • 113 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.